N-(4-(5-(BROMOMETHYL)-1-((2,6-DIFLUOROPHENYL)METHYL)-1,2,3,4-TETRAHYDRO-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXOTHIENO(2,3-D)PYRIMIDIN-6-YL)PHENYL)-N'-METHOXYUREA
UNII MY8TK2L956
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-(5-(bromomethyl)-1-((2,6-difluorophenyl)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-n'-methoxyurea, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MY8TK2L956.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2681381-07-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C27H21BrF2N6O5S OHSXIULICDZKSJ-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-(5-(bromomethyl)-1-((2,6-difluorophenyl)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-n'-methoxyurea. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.